絞り込み

16640

広告

Head-To-Head Comparison of Two Years Efficacy of Entecavir and Tenofovir in Patients with Treatment-Naïve Chronic Hepatitis B--The Real Life Data.

著者
Hepatogastroenterology.2015 Jun ; 62(140):982-6.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (391view , 0users)

Medical

Miscellaneous

Entecavir and tenofovir are generally accepted as first-line therapeutic options in chronic hepatitis B. Both of them are potent and have high genetic barrier to viral resistance. Aim of this study was to compare the two-year efficacy of entecavir and tenofovir in treatment-naive chronic hepatitis B patients.
PMID: 26902041 [PubMed - in process]
印刷用ページを開く Endnote用テキストダウンロード